FM) 2 18 Abstract 19 Mesenchymal stem cells (MSCs)-derived spheroid models favor maintenance of stemness, ex 20 vivo expansion and transplantation efficacy. Spheroids may also be considered as useful 21 surrogate models of the hematopoietic niche. However, accessibility to primary cells, from bone 22 marrow (BM) or adipose tissues, may limit their experimental use and the lack of consistency 23 in methods to form spheroids may affect data interpretation. In this study, we aimed to create a 24 simple model by examining the ability of cell lines, from human (HS-27a and HS-5) and murine 25 (MS-5) BM origins, to form spheroids, compared to primary human MSCs (hMSCs). Our 26 protocol efficiently allowed the spheroid formation from all cell types within 24 hours. Whilst 27 hMSCs-derived spheroids began to shrink after twenty-four hours, the size of spheroids derived 28 from cell lines remained constant during three weeks. The difference was partially explained 29 by the balance between proliferation and cell death, which could be triggered by hypoxia and 30 induced oxidative stress. Our results demonstrate that, unlike hMSCs, MSC cell lines make 31 reproductible spheroids that are easily handled. Thus, this model could help in understanding 32 mechanisms involved in MSC functions and may provide a simple model by which to study 33 cell interactions in the BM niche. 3 34 Introduction 35 Over the last two decades, extensive studies have attempted to characterize 36 mesenchymal stem cell (MSC). Initially described in the bone marrow (BM), MSCs were later 37 found in almost all adult and fetal tissues [1]. Their classification rapidly suffered from a lack 38 of clear phenotypical definition. Therefore, in 2006, the International Society for Cellular 39 Therapy (ISCT) defined MSCs according to three minimal criteria: adherence to plastic, 40 specific cell surface markers and multipotent potential. Indeed, MSCs are classically described 41 as stem cells that are able to differentiate into osteoblasts, adipocytes and chondroblasts [2], 42 making them an attractive source of cells in regenerative medicine. Subsequent studies have 43 also established their ability to differentiate into cardiomyocytes [3], neurons [4], epithelial 44 cells [5] and hepatocytes [6]. The discovery of the multiple functions of MSC, such as those 45 involved in the anti-inflammatory response [7] and in injury repair [8,9] confirmed them as 46 promising cellular tools in regenerative medicine. 47 Furthermore, MSCs represent a key component of the BM microenvironment 48 supporting normal hematopoiesis through the regulation of stem cell renewal and differentiation 49 processes, but also fueling malignant cells and protecting them from therapeutic agents [10]. 50 As such, primary MSCs have often been used as feeder layers in long-term co-culture of 51 hematopoietic cells in vitro in preclinical studies [11]. With the aim of standardization, the 52 murine MS-5 cell line became the gold-standard for both normal or malignant hematopoietic 53 cell culture [12]. This robust co-culture model has been widely used and has contributed to the 54 characterization of hematopoietic stem cells (HSC) [11]. This 2D system, while closer to BM 55 physiology than the culture of hematopoietic cells alone, still lacks the three-dimensional 56 complexity of the BM niche. Thus, although widely used, it is certainly not sufficiently 4 57 consistent at predicting in vivo responses [13]. Therefore, a 3D system might be a better 58 alternative to mimic the BM microenvironment. 59 Critically, the culture leads to rapid loss of MSC pluripotency and supportive functions. 60 Therefore, a wide range of techniques to form 3D MSC structures, from the simplest spheroids 61 to the more complex matrix-based structures, have been proposed [14]. Studies of spheroids, 62 also called mesenspheres, were mostly dedicated to the examination of MSC stemness and 63 differentiation abilities, such as osteogenesis, in order to improve their in vitro expansion and 64 transplantation efficacy in regenerative medicine [15,16]. Furthermore, this model has also 65 been tested as a surrogate niche for hematopoietic cells [17-23]. Spheroids take advantage of 66 the ability of MSCs to self-aggregate, which is improved by using various approaches such as 67 low adhesion plates, natural and artificial (centrifugation) gravity, cell matrix or more complex 68 scaffolds [13,14,24,25]. Classically, studies have used human primary MSCs, from BM, cord 69 blood and lipoaspirate, or rodent sources [15,26].
157 genes were used as endogenous genes for normalization. Primer sequences (S1 Table) Among different methods to form MSC-spheroids, we followed an approach based on 179 cell aggregation in methylcellulose-based medium [27] ( Fig 1A) . To establish a protocol that 180 is simple, reproducible and compatible with hematopoietic cell culture, two commercial 181 methylcelluloses commonly used for hematopoietic cell assays were tested. In general, a range 182 from 0.01 to 1 % of methylcellulose was used [27, [30] [31] [32] [33] ], so we tested three different 183 concentrations (0.25, 0.5 and 1 %). We also tested a hanging drop technique [31,33-35] and 184 the previously described U-bottomed 96-well plates methods [27, 30, 32, 33, 36] . Both techniques 185 worked well for primary hMSCs but the second was more appropriated for further analyses and 186 offered lesser dehydration (data not shown). The SF H4236 methylcellulose at a concentration 187 of 0.5 % was adopted because it generated one spheroid per well with lower condensation 12 233 Electron microscopy observation of the MSCs-derived spheroids 234 Scanning electron microscopy (SEM) confirmed the shrinking of hMSC-derived 235 spheroids ( Fig 3A and S1D Fig) . SEM also revealed at higher magnification that spheroids from 236 hMSCs are highly cohesive, showing tight intercellular connections forming a flat surface, 237 whereas HS-27a, HS-5 and MS-5 spheroids exhibited more rounded cells at their surface 238 ( Fig 3B and S1E Fig) 
